The Pharma-Kongress Produktion & Technik has been recognised for years as the most important industry meeting place for employees and managers from pharmaceutical and biopharmaceutical production and technical service providers. The annual congress is the largest of its kind in Europe. It combines high-calibre conferences on GMP/FDA compliance, a trade exhibition with a traditional social event and plenty of opportunities for networking under one roof.
Speakers from the leading pharmaceutical companies and drug authorities will present on the two days of the conference Case studies in a total of eight conferences. Participants from over 20 countries make the Pharma Congress an international hotspot for pharmaceutical production and technology.
In a special combination of conferences and the „PharmaTechnica“ trade fair, congress participants will be discussing 24 and 25 March 2020 We are once again taking advantage of the opportunity to discuss current trends in detail with colleagues, regulatory authorities and opinion leaders.
PharmaTechnica„ trade fair“
Almost 90 exhibitors will be represented at „PharmaTechnica“ this year. Both congress participants and trade visitors will benefit from technical discussions and an intensive exchange of experiences. In addition to the live demos as part of two conferences, numerous free live demonstrations will once again take place at the trade fair, allowing visitors to experience the new technology directly in practical application.
Exhibitors include Bausch + Ströbel, Harro Höfliger Verpackungsmaschinen, Uhlmann Pac-Systeme, Domino Deutschland, GEA Group, Syntegon Technology, Heuft Systemtechnik, Multivac, Groninger, Romaco and PTI Packaging Technology & Inspection.
The origin of the Pharma Congress is the Pharmaceutical Technology Conference, which this year will once again focus on innovative and sustainable investment projects and their GMP-compliant technical realisation. Based on case studies - from Novartis, Roche, BioNTech, Merck and Oncotec, among others - possible solutions will be presented in a practical manner. The case studies focus on facilities for the production of sterile dosage forms. The programme includes both classic sterile and filling areas as well as a new biotech production facility. The use of robot technology in sterile filling is also part of the conference.
New opportunities through digitalisation
The increasing networking of plants, systems and people through digitalisation is opening up new opportunities for the pharmaceutical industry. The real advantage of Industry 4.0 The main objective is to accelerate decision-making and adaptation processes if the data generated daily, e.g. in monitoring or process control, can be used for this purpose. Aim of the conference Digitalisation and networking is therefore to highlight the current transformation, underpin it with examples and provide an outlook for a digital and networked pharmaceutical industry.
Data integrity has been one of the fundamental GMP principles for years. Despite this, FDA and European inspectors have repeatedly criticised serious violations over the last five years. What they actually expect and how companies deal with data integrity issues during inspections is therefore the subject of the ECA (European Compliance Academy) Conference Data Integrity. Topics covered include how a company can successfully prepare for an inspection, how data integrity issues should be analysed - particularly in the areas of manufacturing and technology - and what responsibilities suppliers have when it comes to complying with data integrity.
Barrier systems in aseptic production
Technologies and compliance in the pharmaceutical industry have been a much-discussed topic at the Pharma Congress for years. aseptic production of medicinal products. The latest technical developments and the current requirements that need to be technically implemented will not only be presented in lectures, but also demonstrated in various live demos.
Protection against microbial contamination is the most important issue for medicinal products manufactured in aseptic processes. Authorities are therefore demanding stricter separation between the operator and the product in the form of a barrier system. The Barrier Systems conference will therefore focus on current issues surrounding the two systems on the market - RABS (Restricted Access Barrier System) and isolators.
Another topic that has been hotly debated for some time is the continuous production of pharmaceuticals - and this could also be the next step towards Process intensification in the development of biopharmaceuticals. The central theme of the ECA's Continuous Bioprocessing conference is therefore the concepts of continuous manufacturing and the degree of their acceptance in the biopharmaceutical industry.
[infotext icon]Pharma Congress compact
Over 1,000 expected participants, almost 90 exhibitors, 60 speakers, 8 conferences
Venue: Crowne Plaza Düsseldorf/Neuss, Rheinallee 1, 41460 Neuss
Event date: 24 and 25 March 2020
Organisation: Concept Heidelberg GmbH, phone: 06221 84 44-0
Information: http://www.pharma-kongress.de and via the Pharma Congress app [/infotext]
